Yu, X., Wang, P., Zhang, Y., Wang, R., Li, X., Ma, W., Song, Z., Luo, S., An, S., Liu, F., Jia, R., Yang, Z., Tan, Y., Yang, D., Zhang, J., Jing, D., Wu, Z., Tian, W., Cheng, X. (2026). Phase I study of IMM2510, a PD-L1/ VEGF bispecific antibody, in participants with advanced IO-treated SQ-NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8580